Arcus Biosciences
Patents, Design & Utilities
Last updated:
List of all Arcus Biosciences patents 31 in total
| Status | Patent |
|---|---|
Application | Utility: TREATMENT OF ONCOGENE-DRIVEN CANCERS Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: PROCESSES FOR PREPARING AMINOPYRIMIDINE COMPOUNDS Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: TREATMENT OF CANCER UTILIZING AN IDENTIFIED ADENOSINE FINGERPRINT Filling date: 26 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS Filling date: 26 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Inhibitors of CD73-mediated immunosuppression Filling date: 26 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: ANTIBODIES TO TIGIT Filling date: 26 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF Filling date: 26 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: INHIBITORS OF ARG1 AND/OR ARG2 Filling date: 26 Sep 2025 Issue date: 20 Jan 2022 |
Grant | Utility: Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders Filling date: 26 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: CRYSTALLINE FORMS OF A CD73 INHIBITOR AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: CD73 INHIBITORS Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: SOLID FORMS OF AN AZOLOPYRIMIDINE COMPOUND Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Azolopyrimidine for the treatment of cancer-related disorders Filling date: 26 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS Filling date: 26 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Inhibitors of adenosine 5'-nucleotidase Filling date: 26 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Quinazoline-pyridine derivatives for the treatment of cancer-related disorders Filling date: 26 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: PYRIDONE A2R ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Modulators of 5'-nucleotidase, ecto and the use thereof Filling date: 26 Sep 2025 Issue date: 11 May 2021 |
Grant | Utility: Modulators of 5'-nucleotidase, ecto and the use thereof Filling date: 26 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS Filling date: 26 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: ARGINASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS Filling date: 26 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: DOSING WITH AN AZOLOPYRIMIDINE COMPOUND Filling date: 26 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE Filling date: 26 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: QUINAZOLINE-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS Filling date: 26 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: INHIBITORS OF CD73-MEDIATED IMMUNOSUPPRESSION Filling date: 26 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF Filling date: 26 Sep 2025 Issue date: 10 Oct 2019 |
Grant | Utility: Azolopyrimidine for the treatment of cancer-related disorders Filling date: 26 Sep 2025 Issue date: 3 Sep 2019 |
Showing 1 to 31 of 31 patents.